{"id":"W2144547786","doi":"10.1158/1078-0432.ccr-11-2436","title":"Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Temsirolimus; Sorafenib; Medicine; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neuroblastoma RAS viral oncogene homolog; Cancer; Gastroenterology; Phases of clinical research; Toxicity; Surgery; Hepatocellular carcinoma; KRAS; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393367,0.001675729,0.002268654,0.0004189145,0.0004272582,0.0006827973,0.0008624401,0.0008806473,0.003111759],"category_scores_gemma":[0.0007115402,0.0006848256,0.0009562219,0.0003586908,0.0007462476,0.0005737744,0.000324785,0.00275313,0.0009527326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007429141,"about_ca_system_score_gemma":0.001715533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005789191,"about_ca_topic_score_gemma":0.001537505,"domain_scores_codex":[0.9995833,0.0001866947,0.00002398208,0.00006126468,0.00005847785,0.00008628112],"domain_scores_gemma":[0.9994112,0.00006211843,0.000101665,0.00003029606,0.00003439527,0.0003603389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5766771,0.1132566,0.01291964,0.001715656,0.001947725,0.001041968,0.0004267392,0.005595439,0.1200536,0.0004413954,0.009781688,0.1561424],"study_design_scores_gemma":[0.5165944,0.4595424,0.01219114,0.00004803538,0.0003771907,0.0007185432,0.00004028235,0.001649297,0.005019741,0.0001480465,0.003638003,0.00003301553],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904979,0.003430363,0.0007579623,0.0006409021,0.0001742025,0.002149087,0.000525458,0.0001326762,0.001691523],"genre_scores_gemma":[0.9905075,0.001896368,0.001841818,0.000568461,0.0003119876,0.001745219,0.001226844,0.00002588298,0.001875926],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003111759,"threshold_uncertainty_score":0.01040983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1270920474656933,"score_gpt":0.4640427284017923,"score_spread":0.336950680936099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}